- Home
- CVBF vs SRRK Comparison
CVBF vs SRRK Comparison
Compare CVBF & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVBF
- SRRK
- Stock Information
- Founded
- CVBF 1974
- SRRK 2012
- Country
- CVBF United States
- SRRK United States
- Employees
- CVBF N/A
- SRRK N/A
- Industry
- CVBF Major Banks
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVBF Finance
- SRRK Health Care
- Exchange
- CVBF Nasdaq
- SRRK Nasdaq
- Market Cap
- CVBF 2.7B
- SRRK 2.8B
- IPO Year
- CVBF N/A
- SRRK 2018
- Fundamental
- Price
- CVBF $18.75
- SRRK $29.01
- Analyst Decision
- CVBF Buy
- SRRK Strong Buy
- Analyst Count
- CVBF 4
- SRRK 6
- Target Price
- CVBF $23.50
- SRRK $42.17
- AVG Volume (30 Days)
- CVBF 545.1K
- SRRK 1.1M
- Earning Date
- CVBF 07-23-2025
- SRRK 05-14-2025
- Dividend Yield
- CVBF 4.27%
- SRRK N/A
- EPS Growth
- CVBF N/A
- SRRK N/A
- EPS
- CVBF 1.45
- SRRK N/A
- Revenue
- CVBF $506,920,000.00
- SRRK N/A
- Revenue This Year
- CVBF N/A
- SRRK N/A
- Revenue Next Year
- CVBF $5.98
- SRRK $452.64
- P/E Ratio
- CVBF $12.93
- SRRK N/A
- Revenue Growth
- CVBF N/A
- SRRK N/A
- 52 Week Low
- CVBF $15.91
- SRRK $6.76
- 52 Week High
- CVBF $24.58
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- CVBF 46.00
- SRRK 42.82
- Support Level
- CVBF $18.63
- SRRK $28.54
- Resistance Level
- CVBF $19.32
- SRRK $31.60
- Average True Range (ATR)
- CVBF 0.33
- SRRK 1.56
- MACD
- CVBF -0.13
- SRRK -0.17
- Stochastic Oscillator
- CVBF 7.89
- SRRK 14.10
About CVBF CVB Financial Corporation
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.